{
  "resourceType" : "CodeSystem",
  "id" : "enlist-lot-setting",
  "language" : "en",
  "text" : {
    "status" : "generated",
    "div" : "<div xml:lang=\"en\" lang=\"en\"><hr/><p><b>English</b></p><hr/><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem enlist-lot-setting</b></p><a name=\"en-enlist-lot-setting\"> </a><a name=\"en-hcenlist-lot-setting\"> </a><p>This case-sensitive code system <code>https://bih-cei.de/fhir/therapieziele-onkologie/CodeSystem/enlist-lot-setting</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style=\"white-space:nowrap\">eLoT<a name=\"en-enlist-lot-setting-eLoT\"> </a></td><td>eLoT — frühes Setting</td><td>Early-stage Line of Therapy: resektable Situation — neoadjuvante, adjuvante und perioperative Systemtherapie.</td></tr><tr><td style=\"white-space:nowrap\">aLoT<a name=\"en-enlist-lot-setting-aLoT\"> </a></td><td>aLoT — fortgeschrittenes Setting</td><td>Advanced-stage Line of Therapy: lokal fortgeschrittene oder metastasierte Situation.</td></tr><tr><td style=\"white-space:nowrap\">iLoT<a name=\"en-enlist-lot-setting-iLoT\"> </a></td><td>iLoT — investigational</td><td>Investigational Line of Therapy: Systemtherapie mit ausschließlich nicht EMA/FDA-zugelassenen Komponenten, unabhängig vom Setting; eigene Zählachse.</td></tr></table></div>"
  },
  "url" : "https://bih-cei.de/fhir/therapieziele-onkologie/CodeSystem/enlist-lot-setting",
  "version" : "1.0.0-ballot",
  "name" : "EnlistLotSetting",
  "title" : "EnLiST setting axes",
  "status" : "draft",
  "date" : "2026-08-03T05:20:25+00:00",
  "publisher" : "Berlin Institute of Health at Charité (BIH)",
  "contact" : [{
    "name" : "Berlin Institute of Health at Charité (BIH)",
    "telecom" : [{
      "system" : "url",
      "value" : "https://www.bihealth.org"
    }]
  }],
  "description" : "The three separately counted setting axes of the EnLiST notation: eLoT early, aLoT advanced, iLoT investigational.",
  "jurisdiction" : [{
    "coding" : [{
      "system" : "urn:iso:std:iso:3166",
      "code" : "DE",
      "display" : "Germany"
    }]
  }],
  "caseSensitive" : true,
  "content" : "complete",
  "count" : 3,
  "concept" : [{
    "code" : "eLoT",
    "display" : "eLoT — frühes Setting",
    "definition" : "Early-stage Line of Therapy: resektable Situation — neoadjuvante, adjuvante und perioperative Systemtherapie."
  },
  {
    "code" : "aLoT",
    "display" : "aLoT — fortgeschrittenes Setting",
    "definition" : "Advanced-stage Line of Therapy: lokal fortgeschrittene oder metastasierte Situation."
  },
  {
    "code" : "iLoT",
    "display" : "iLoT — investigational",
    "definition" : "Investigational Line of Therapy: Systemtherapie mit ausschließlich nicht EMA/FDA-zugelassenen Komponenten, unabhängig vom Setting; eigene Zählachse."
  }]
}